Big strides in cancer treatment bring us closer to breakthroughs
- Bias Rating
-16% Somewhat Liberal
- Reliability
60% ReliableFair
- Policy Leaning
-12% Somewhat Liberal
- Politician Portrayal
24% Positive
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Continue For Free
Create your free account to see the in-depth bias analytics and more.
Continue
Continue
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates. Already a member: Log inBias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
-16% Negative
- Liberal
| Sentence | Sentiment | Bias |
|---|---|---|
| "As the GLP toxicology studies that have been completed in rats and non-human primates have not identified any safety or tolerability issues associated with the administration of PAT-DX1, this is expected to be the final step before Patrys can commence engaging clinicians and trial sites in order to formally initiate the clinical trial process." | Positive | 12% Conservative |
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Contributing sentiments towards policy:
56% : "As the GLP toxicology studies that have been completed in rats and non-human primates have not identified any safety or tolerability issues associated with the administration of PAT-DX1, this is expected to be the final step before Patrys can commence engaging clinicians and trial sites in order to formally initiate the clinical trial process.*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.